Pathstone Holdings’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.15M | Sell |
238,991
-10,672
| -4% | -$409K | 0.04% | 352 |
|
|
2025
Q1 | $9.68M | Sell |
249,663
-7,052
| -3% | -$273K | 0.04% | 352 |
|
|
2024
Q4 | $8.69M | Buy |
256,715
+10,101
| +4% | +$342K | 0.04% | 364 |
|
|
2024
Q3 | $10.1M | Buy |
246,614
+26,707
| +12% | +$1.09M | 0.04% | 311 |
|
|
2024
Q2 | $8.47M | Buy |
219,907
+6,773
| +3% | +$261K | 0.04% | 354 |
|
|
2024
Q1 | $9.14M | Buy |
213,134
+17,592
| +9% | +$754K | 0.04% | 319 |
|
|
2023
Q4 | $7.25M | Buy |
+195,542
| New | +$7.25M | 0.04% | 332 |
|